Logo image of ORKT

ORANGEKLOUD TECHNOLOGY INC (ORKT) Stock Fundamental Analysis

USA - NASDAQ:ORKT - KYG6781F1019 - Common Stock

2.03 USD
-0.2 (-8.97%)
Last: 10/10/2025, 5:11:25 PM
2.08 USD
+0.05 (+2.46%)
After Hours: 10/10/2025, 5:11:25 PM
Fundamental Rating

2

ORKT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. While ORKT seems to be doing ok healthwise, there are quite some concerns on its profitability. ORKT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ORKT has reported negative net income.
ORKT had a negative operating cash flow in the past year.
ORKT Yearly Net Income VS EBIT VS OCF VS FCFORKT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -62.36%, ORKT is not doing good in the industry: 90.70% of the companies in the same industry are doing better.
ORKT's Return On Equity of -73.69% is on the low side compared to the rest of the industry. ORKT is outperformed by 81.40% of its industry peers.
Industry RankSector Rank
ROA -62.36%
ROE -73.69%
ROIC N/A
ROA(3y)-18.46%
ROA(5y)N/A
ROE(3y)-22.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ORKT Yearly ROA, ROE, ROICORKT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 26.36%, ORKT is doing worse than 69.77% of the companies in the same industry.
ORKT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ORKT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.59%
GM growth 5YN/A
ORKT Yearly Profit, Operating, Gross MarginsORKT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150 -200

5

2. Health

2.1 Basic Checks

ORKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ORKT has been increased compared to 1 year ago.
Compared to 1 year ago, ORKT has an improved debt to assets ratio.
ORKT Yearly Shares OutstandingORKT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORKT Yearly Total Debt VS Total AssetsORKT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 2.42 indicates that ORKT is not a great score, but indicates only limited risk for bankruptcy at the moment.
ORKT's Altman-Z score of 2.42 is in line compared to the rest of the industry. ORKT outperforms 41.86% of its industry peers.
ORKT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
ORKT has a Debt to Equity ratio of 0.02. This is in the better half of the industry: ORKT outperforms 77.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 2.42
ROIC/WACCN/A
WACC8.56%
ORKT Yearly LT Debt VS Equity VS FCFORKT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

ORKT has a Current Ratio of 5.98. This indicates that ORKT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.98, ORKT belongs to the top of the industry, outperforming 91.86% of the companies in the same industry.
ORKT has a Quick Ratio of 5.98. This indicates that ORKT is financially healthy and has no problem in meeting its short term obligations.
ORKT's Quick ratio of 5.98 is amongst the best of the industry. ORKT outperforms 91.86% of its industry peers.
Industry RankSector Rank
Current Ratio 5.98
Quick Ratio 5.98
ORKT Yearly Current Assets VS Current LiabilitesORKT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

ORKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -586.47%.
ORKT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.66%.
ORKT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.29% yearly.
EPS 1Y (TTM)-586.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-603%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y-6.29%
Revenue growth 5YN/A
Sales Q2Q%-76.78%

3.2 Future

The Earnings Per Share is expected to grow by 22.48% on average over the next years. This is a very strong growth
ORKT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.74% yearly.
EPS Next Y-179.99%
EPS Next 2Y22.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.14%
Revenue Next 2Y20.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ORKT Yearly Revenue VS EstimatesORKT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M
ORKT Yearly EPS VS EstimatesORKT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.05 -0.1 -0.15 -0.2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ORKT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORKT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORKT Price Earnings VS Forward Price EarningsORKT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORKT Per share dataORKT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

ORKT's earnings are expected to grow with 22.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.48%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ORKT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORANGEKLOUD TECHNOLOGY INC

NASDAQ:ORKT (10/10/2025, 5:11:25 PM)

After market: 2.08 +0.05 (+2.46%)

2.03

-0.2 (-8.97%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-02 2025-05-02/dmh
Earnings (Next)N/A N/A
Inst Owners0.78%
Inst Owner ChangeN/A
Ins Owners7.15%
Ins Owner ChangeN/A
Market Cap11.86M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.5
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)-1.43
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-1.37
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS0.81
BVpS1.79
TBVpS1.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.36%
ROE -73.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.36%
FCFM N/A
ROA(3y)-18.46%
ROA(5y)N/A
ROE(3y)-22.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.59%
GM growth 5YN/A
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 156.35%
Cap/Sales 7.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.98
Quick Ratio 5.98
Altman-Z 2.42
F-Score3
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)132.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-586.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-603%
EPS Next Y-179.99%
EPS Next 2Y22.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y-6.29%
Revenue growth 5YN/A
Sales Q2Q%-76.78%
Revenue Next Year4.14%
Revenue Next 2Y20.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-518.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-101.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-867.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-884.15%
OCF growth 3YN/A
OCF growth 5YN/A